Teva Pharmaceutical (TEVA) Misses Q4 EPS Views; Guides
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) reports Q4 adj earnings of $0.53 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
